Literature DB >> 31822860

Animal models of scarring control.

David L Williams1.   

Abstract

Filtration surgery has, for the past 50 years been key in the treatment of glaucoma yet a significant issue in the long-term success of such surgery is fibrosis limiting aqueous drainage. Numerous methods have been used to reduce such scarring after filtration surgery and animal models have been important in the development of such techniques. First animal models have been central in understanding molecular and cellular changes occurring in fibrosis and thus which pathways might be valuable therapeutic. Secondly animal models have been critical in determining which of these therapies is likely to be most worthwhile. Having said that animals differ substantially from humans in the anatomy of their aqueous drainage pathways and in the mechanisms of fibrotic change. Rodents and lagomorphs vary more markedly from humans than do primates at an anatomic, biochemical and physiological level, and thus the latter might seem more appropriate as models for antifibrotic techniques. However the welfare implications, and thus ethical issues, in using primates are more concerning than with rodents or rabbits and efforts to refine, reduce and replace living animals in such model systems are crucially important. One problem is that the animal models normally involve healthy eyes, not ones with glaucoma. In veterinary ophthalmology we see large numbers of dogs with glaucoma, many of which have filtration implants placed. Potentially these could be a valuable animal model where benefits of antifibrotic treatment could benefit the animals involved and the research seeking to optimise such treatments.

Entities:  

Mesh:

Year:  2019        PMID: 31822860      PMCID: PMC7002449          DOI: 10.1038/s41433-019-0727-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  61 in total

1.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

2.  Trabeculectomy. Preliminary report of a new method.

Authors:  J E Cairns
Journal:  Am J Ophthalmol       Date:  1968-10       Impact factor: 5.258

3.  Ethics and clinical research.

Authors:  H K Beecher
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

4.  New implant for drainage in glaucoma. Animal trial.

Authors:  A C Molteno
Journal:  Br J Ophthalmol       Date:  1969-03       Impact factor: 4.638

5.  Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important?

Authors:  D Broadway; I Grierson; R Hitchings
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

6.  Combined transscleral diode laser cyclophotocoagulation and Ahmed gonioimplantation in dogs with primary glaucoma: 51 cases (1996-2004).

Authors:  John S Sapienza; Alexandra van der Woerdt
Journal:  Vet Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 1.644

7.  Long-term evaluation of the use of Ahmed gonioimplants in dogs with primary glaucoma: nine cases (2000-2008).

Authors:  Hans D Westermeyer; Diane V H Hendrix; Daniel A Ward
Journal:  J Am Vet Med Assoc       Date:  2011-03-01       Impact factor: 1.936

8.  Use of a 350-mm2 Baerveldt glaucoma drainage device to maintain vision and control intraocular pressure in dogs with glaucoma: a retrospective study (2013-2016).

Authors:  Kathleen L Graham; David Donaldson; Francis A Billson; F Mark Billson
Journal:  Vet Ophthalmol       Date:  2016-11-16       Impact factor: 1.644

9.  Genotype-Phenotype Associations of IL6 and PRG4 With Conjunctival Fibrosis After Glaucoma Surgery.

Authors:  Cynthia Yu-Wai-Man; Aristides D Tagalakis; Jinhong Meng; Yann Bouremel; Richard M H Lee; Alex Virasami; Stephen L Hart; Peng T Khaw
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

10.  Keloid scarring: understanding the genetic basis, advances, and prospects.

Authors:  Ahmad Sukari Halim; Azadeh Emami; Iman Salahshourifar; Thirumulu Ponnuraj Kannan
Journal:  Arch Plast Surg       Date:  2012-05-10
View more
  1 in total

1.  Biocompatibility and feasibility of VisiPlate, a novel ultrathin, multichannel glaucoma drainage device.

Authors:  Brandon W Kao; Elana Meer; Thomas A Barbolt; Richard A Lewis; Iqbal Ike Ahmed; Vivian Lee; Samuel M Nicaise; Georgia Griggs; Eydie G Miller-Ellis
Journal:  J Mater Sci Mater Med       Date:  2021-11-24       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.